Dashboard
Manage Tickers

G Genpact LTD

NYSE genpact.com


$ 39.49 $ -0.29 (-0.73 %)    

Friday, 24-Oct-2025 15:59:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 617.50 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.25 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.59 $ -1.27 (-0.34 %)
$ 39.49
$ 40.07
$ 39.50 x 20
$ 40.50 x 2,201
$ 39.44 - $ 40.07
$ 37.27 - $ 56.12
1,427,990
na
6.88B
$ 0.83
$ 12.78
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-11-2025 06-30-2025 10-Q
2 05-12-2025 03-31-2025 10-Q
3 03-03-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-09-2024 06-30-2024 10-Q
6 05-10-2024 03-31-2024 10-Q
7 02-29-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-10-2023 03-31-2023 10-Q
11 03-01-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-10-2022 03-31-2022 10-Q
15 03-01-2022 12-31-2021 10-K
16 11-09-2021 09-30-2021 10-Q
17 08-09-2021 06-30-2021 10-Q
18 05-10-2021 03-31-2021 10-Q
19 03-01-2021 12-31-2020 10-K
20 11-09-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 05-11-2020 03-31-2020 10-Q
23 03-02-2020 12-31-2019 10-K
24 11-08-2019 09-30-2019 10-Q
25 08-09-2019 06-30-2019 10-Q
26 05-10-2019 03-31-2019 10-Q
27 03-01-2019 12-31-2018 10-K
28 11-09-2018 09-30-2018 10-Q
29 08-09-2018 06-30-2018 10-Q
30 05-10-2018 03-31-2018 10-Q
31 03-01-2018 12-31-2017 10-K
32 11-09-2017 09-30-2017 10-Q
33 08-09-2017 06-30-2017 10-Q
34 05-10-2017 03-31-2017 10-Q
35 03-01-2017 12-31-2016 10-K
36 11-08-2016 09-30-2016 10-Q
37 08-08-2016 06-30-2016 10-Q
38 05-09-2016 03-31-2016 10-Q
39 02-26-2016 12-31-2015 10-K
40 11-06-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
CORRECTION: Ratings Headline Titled "Citig...
10/22/2025 22:36:40

CORRECTION: Citigroup analyst Bryan Keane initiates coverage on Genpact (NYSE:G) with a Neutral rating and announces Price Targ...

citigroup-initiates-coverage-on-genpact-with-neutral-rating-announces-price-target-of-43
Citigroup Initiates Coverage On Genpact wi...
10/22/2025 22:34:29

Citigroup analyst Bryan Keane initiates coverage on Genpact (NYSE:G) with a Neutral rating and announces Price Target of $43.

where-genpact-stands-with-analysts
Where Genpact Stands With Analysts
08/20/2025 18:01:55

jp-morgan-maintains-neutral-on-genpact-lowers-price-target-to-50
JP Morgan Maintains Neutral on Genpact, Lo...
08/20/2025 15:21:23

JP Morgan analyst Tien-Tsin Huang maintains Genpact (NYSE:G) with a Neutral and lowers the price target from $55 to $50.

needham-maintains-buy-on-genpact-raises-price-target-to-53
Needham Maintains Buy on Genpact, Raises P...
08/08/2025 09:59:03

Needham analyst Mayank Tandon maintains Genpact (NYSE:G) with a Buy and raises the price target from $50 to $53.

genpact-sees-q3-gaap-eps-074-075-vs-074-est
Genpact Sees Q3 GAAP EPS $0.74-$0.75 vs $0...
08/07/2025 21:33:48

Reconciliation of Outlook for Diluted EPS to Adjusted Diluted EPS9(Per share data)   Quarter ending September 30, 2025  Lower U...

genpact-raises-fy2025-gaap-eps-guidance-from-290-301-to-298-305-vs-300-est
Genpact Raises FY2025 GAAP EPS Guidance fr...
08/07/2025 21:30:40

Reconciliation of Outlook for Diluted EPS to Adjusted Diluted EPS8(Per share data)   Year ending December 31, 2025  Lower Upper...

genpact-raises-fy2025-adj-eps-guidance-from-341-352-to-351-358-vs-347-est-raises-fy2025-sales-guidance-from-486b-500b-to-496b-505b-vs-496b-est
Genpact Raises FY2025 Adj EPS Guidance fro...
08/07/2025 20:28:47

genpact-sees-q3-adj-eps-089-090-vs-088-est-sees-sales-1258m-1270m-vs-125b-est
Genpact Sees Q3 Adj EPS $0.89-$0.90 vs $0....
08/07/2025 20:27:42

genpact-q2-adj-eps-088-beats-085-estimate-sales-125b-beat-123b-estimate
Genpact Q2 Adj. EPS $0.88 Beats $0.85 Esti...
08/07/2025 20:11:42

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

price-over-earnings-overview-genpact
Price Over Earnings Overview: Genpact
07/31/2025 15:00:26

deutsche-bank-reinstates-hold-on-genpact-announces-47-price-target
Deutsche Bank Reinstates Hold on Genpact, ...
07/17/2025 15:50:03

Deutsche Bank analyst Bryan Keane reinstates Genpact (NYSE:G) with a Hold and announces $47 price target.

pe-ratio-insights-for-genpact
P/E Ratio Insights for Genpact
07/03/2025 15:00:25

mizuho-maintains-neutral-on-genpact-raises-price-target-to-51
Mizuho Maintains Neutral on Genpact, Raise...
07/01/2025 18:12:15

Mizuho analyst Dan Dolev maintains Genpact (NYSE:G) with a Neutral and raises the price target from $48 to $51.

needham-reiterates-buy-on-genpact-maintains-50-price-target
Needham Reiterates Buy on Genpact, Maintai...
06/30/2025 10:36:14

Needham analyst Mayank Tandon reiterates Genpact (NYSE:G) with a Buy and maintains $50 price target.

genpact-acquires-xponentl-data-financial-details-of-the-transaction-were-not-disclosed
Genpact Acquires XponentL Data; Financial ...
06/05/2025 21:07:48

Combination will fast-track Genpact's expansion of advanced technology solutions, amplifying data and AI capabilities, doma...

genpact-analysts-cut-their-forecasts-after-q1-results
Genpact Analysts Cut Their Forecasts After...
05/08/2025 13:27:13

baird-maintains-neutral-on-genpact-lowers-price-target-to-50
Baird Maintains Neutral on Genpact, Lowers...
05/08/2025 13:19:16

Baird analyst David Koning maintains Genpact (NYSE:G) with a Neutral and lowers the price target from $56 to $50.

arm-holdings-fluence-energy-semrush-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Arm Holdings, Fluence Energy, Semrush And ...
05/08/2025 12:29:35

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION